oNKo-innate Pty Ltd is founded in 2017, operates from its headquarter in Melbourne, VIC 3000, AU. The company operates in the Hospitals & Healthcare, Medical Practices sector.
oNKo-innate Pty Ltd specializes in Innate immune drug discovery, Therapeutic target validation, Emerging therapeutic target prosecution, Full-stack biology platforms, Modality platforms, and offers services including Innate immune drug discovery, Drug development platforms, and Therapeutic target validation.